{"id":4572,"date":"2020-05-04T14:04:16","date_gmt":"2020-05-04T12:04:16","guid":{"rendered":"https:\/\/www.anderapartners.com\/?p=4572"},"modified":"2020-09-25T18:01:43","modified_gmt":"2020-09-25T16:01:43","slug":"le-groupe-bioclinic-acquiert-biomega","status":"publish","type":"post","link":"https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/","title":{"rendered":"Le groupe Bioclinic acquiert Biomega"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-2847\" src=\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2019\/01\/Bioclinic-2-1.png\" alt=\"\" width=\"1036\" height=\"503\" srcset=\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2019\/01\/Bioclinic-2-1.png 1036w, https:\/\/www.anderapartners.com\/wp-content\/uploads\/2019\/01\/Bioclinic-2-1-768x373.png 768w, https:\/\/www.anderapartners.com\/wp-content\/uploads\/2019\/01\/Bioclinic-2-1-285x138.png 285w, https:\/\/www.anderapartners.com\/wp-content\/uploads\/2019\/01\/Bioclinic-2-1-446x217.png 446w, https:\/\/www.anderapartners.com\/wp-content\/uploads\/2019\/01\/Bioclinic-2-1-385x187.png 385w\" sizes=\"auto, (max-width: 1036px) 100vw, 1036px\" \/><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Un peu plus d\u2019un an apr\u00e8s leur entr\u00e9e au capital du groupe Bioclinic, le consortium compos\u00e9 d\u2019IDIA Capital Investissement, de Socadif Capital Investissement et d\u2019Andera Partners accompagne la strat\u00e9gie de croissance externe de Bioclinic en acqu\u00e9rant 100\u00a0% du groupe Biomega.<\/strong><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p>Le groupe cr\u00e9\u00e9 en 1995 par le Dr Philippe Dabi poursuit sa strat\u00e9gie de consolidation en Ile-de-France. Apr\u00e8s avoir r\u00e9alis\u00e9 trois acquisitions depuis l\u2019entr\u00e9e au capital de ses nouveaux actionnaires financiers, le groupe Bioclinic acquiert Biomega, op\u00e9rateur leader dans le d\u00e9partement du Val de Marne.<\/p>\n<p>Fort de cette acquisition, le groupe Bioclinic intensifie sa pr\u00e9sence dans le sud-est de Paris avec 13 nouveaux sites de pr\u00e9l\u00e8vement certifi\u00e9s 100\u00a0% COFRAC, un plateau technique et r\u00e9alisant pr\u00e8s de 17\u00a0M\u20ac de chiffre d\u2019affaires.<\/p>\n<p>Avec 86 sites de pr\u00e9l\u00e8vement r\u00e9partis sur les 8 d\u00e9partements de l\u2019Ile-de-France, Bioclinic confirme sa position de leader de l\u2019analyse m\u00e9dicale en r\u00e9gion parisienne et s\u2019affirme comme le consolidateur privil\u00e9gi\u00e9 du secteur sur ces d\u00e9partements. \u00ab\u00a0Le r\u00e9seau de Philippe Dabi et son savoir-faire pour int\u00e9grer les cibles nous permettent de disposer d\u2019un <em>pipe<\/em> d\u2019acquisitions de grande qualit\u00e9 en Ile-de-France, mais aussi dans d\u2019autres r\u00e9gions fran\u00e7aises. Nous pr\u00e9voyons de poursuivre notre croissance et de parvenir \u00e0 plus de 100\u00a0M\u20ac de chiffre d\u2019affaires en Ile-de-France\u00a0\u00bb commentent conjointement Marie-Christine Maurice et Martin M\u00e9zi\u00e8res, respectivement Directrice de participations et Analyste chez IDIA Capital Investissement. Cette strat\u00e9gie de croissance est soutenue par le tour de table actuel mais aussi par Andera Partners en financement mezzanine et par le pool bancaire historique dirig\u00e9 par le LCL. \u00ab\u00a0Au b\u00e9n\u00e9fice de cette op\u00e9ration nous doublons notre investissement initial de d\u00e9cembre 2018. Fort de la solide visibilit\u00e9 sur les niveaux de remboursement des analyses pour les trois prochaines ann\u00e9es, nous sommes convaincus de l\u2019excellence du groupe et de la vision strat\u00e9gique de son pr\u00e9sident le Dr Philippe Dabi \u00bb rajoute Emmanuel David, Directeur G\u00e9n\u00e9ral de Socadif Capital Investissement.<\/p>\n<p>\u00ab\u00a0Nous sommes ravis d\u2019avoir pu soutenir de mani\u00e8re r\u00e9active et ferme le groupe Bioclinic au cours du processus d\u2019ench\u00e8re organis\u00e9 par la banque Edmond de Rothschild Corporate Finance qui a r\u00e9uni uniquement des industriels du secteur. Cette acquisition porteuse de fortes synergies, r\u00e9pond parfaitement \u00e0 la strat\u00e9gie de d\u00e9veloppement du groupe, qui poursuit son maillage dense en Ile-de-France et en appelle d\u2019autres\u00a0\u00bb commente Arnaud Faure, associ\u00e9 d\u2019Andera Partners.<\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p>Liste des intervenants sur l\u2019op\u00e9ration :<\/p>\n<p><u>Acqu\u00e9reurs<\/u><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong>Bioclinic <\/strong>: Dr Philippe Dabi, Management<\/p>\n<p><strong>IDIA Capital Investissement <\/strong>: Marie-Christine Maurice, Martin M\u00e9zi\u00e8res<\/p>\n<p><strong>Socadif Capital Investissement <\/strong>: Emmanuel David, Matthieu Chevallier<\/p>\n<p><strong>ActoMezz- Andera Partners\u00a0:<\/strong> Arnaud Faure, Christine Martinovic, Pierre-Luc Wilain de Leymarie<\/p>\n<p>&nbsp;<\/p>\n<p><em>Conseil juridique et fiscal Management\u00a0: Lamartine (Fabien Mauvais, Philippe Barouch, Emma Thibaud, Emilie Renaud)<\/em><\/p>\n<p><em>Conseil juridique Mezzanine\u00a0: McDermott Will &amp; Emery (Pierre-Arnoux Mayoly, Benjamin Briand)<\/em><\/p>\n<p><em>Conseil Juridique Banques : Bryan Cave Leighton Paisner (Olivier Borenstejn, Fanny Chen, Emmanuel Le Galloc\u2019h)<\/em><\/p>\n<p><em>DD financi\u00e8re\u00a0: Accuracy (Arnaud Lambert, Vincent Savajols, Andrea Giannone)<\/em><\/p>\n<p><u>\u00a0<\/u><\/p>\n<p><u>C\u00e9dants<\/u><\/p>\n<p><strong>Biom\u00e9ga<\/strong>\u00a0: Management<\/p>\n<p>&nbsp;<\/p>\n<p><em>Conseil financier c\u00e9dants\u00a0: Edmond de Rothschild Corporate Finance (S\u00e9bastien Auger, Boris Martin, Adam Lado)<\/em><\/p>\n<p><em>Conseil juridique\u00a0: HPML (Thomas Hermetet, Marina Llobell)<\/em><\/p>\n<p><em>VDD financi\u00e8re\u00a0: Od\u00e9ris (Aur\u00e9lien Vion, Eddy Chagu\u00e9)<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; Un peu plus d\u2019un an apr\u00e8s leur entr\u00e9e au capital du groupe Bioclinic, le consortium compos\u00e9 d\u2019IDIA Capital Investissement, de Socadif Capital Investissement et d\u2019Andera Partners accompagne la strat\u00e9gie de croissance externe de Bioclinic en acqu\u00e9rant 100\u00a0% du groupe Biomega. \u00a0 Le groupe cr\u00e9\u00e9 en 1995 par le Dr Philippe Dabi poursuit sa strat\u00e9gie&#8230;<\/p>\n","protected":false},"author":2,"featured_media":2847,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[79],"class_list":["post-4572","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actomezz"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Le groupe Bioclinic acquiert Biomega - ANDERA PARTNERS<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Le groupe Bioclinic acquiert Biomega - ANDERA PARTNERS\" \/>\n<meta property=\"og:description\" content=\"&nbsp; Un peu plus d\u2019un an apr\u00e8s leur entr\u00e9e au capital du groupe Bioclinic, le consortium compos\u00e9 d\u2019IDIA Capital Investissement, de Socadif Capital Investissement et d\u2019Andera Partners accompagne la strat\u00e9gie de croissance externe de Bioclinic en acqu\u00e9rant 100\u00a0% du groupe Biomega. \u00a0 Le groupe cr\u00e9\u00e9 en 1995 par le Dr Philippe Dabi poursuit sa strat\u00e9gie...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/\" \/>\n<meta property=\"og:site_name\" content=\"ANDERA PARTNERS\" \/>\n<meta property=\"article:published_time\" content=\"2020-05-04T12:04:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-09-25T16:01:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2019\/01\/Bioclinic-2-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1036\" \/>\n\t<meta property=\"og:image:height\" content=\"503\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Nicolas Delsert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nicolas Delsert\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/\"},\"author\":{\"name\":\"Nicolas Delsert\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/dce1d4a32f2d85f191a44527e202942c\"},\"headline\":\"Le groupe Bioclinic acquiert Biomega\",\"datePublished\":\"2020-05-04T12:04:16+00:00\",\"dateModified\":\"2020-09-25T16:01:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/\"},\"wordCount\":569,\"publisher\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2019\/01\/Bioclinic-2-1.png\",\"articleSection\":[\"andera Acto\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/\",\"url\":\"https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/\",\"name\":\"Le groupe Bioclinic acquiert Biomega - ANDERA PARTNERS\",\"isPartOf\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2019\/01\/Bioclinic-2-1.png\",\"datePublished\":\"2020-05-04T12:04:16+00:00\",\"dateModified\":\"2020-09-25T16:01:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/#primaryimage\",\"url\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2019\/01\/Bioclinic-2-1.png\",\"contentUrl\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2019\/01\/Bioclinic-2-1.png\",\"width\":1036,\"height\":503},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.anderapartners.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Le groupe Bioclinic acquiert Biomega\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#website\",\"url\":\"https:\/\/www.anderapartners.com\/fr\/\",\"name\":\"ANDERA PARTNERS\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.anderapartners.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#organization\",\"name\":\"Andera Partners\",\"url\":\"https:\/\/www.anderapartners.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg\",\"contentUrl\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg\",\"width\":107,\"height\":44,\"caption\":\"Andera Partners\"},\"image\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/dce1d4a32f2d85f191a44527e202942c\",\"name\":\"Nicolas Delsert\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/fca7b29302058c85588bc6bc3db9bd1e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/fca7b29302058c85588bc6bc3db9bd1e?s=96&d=mm&r=g\",\"caption\":\"Nicolas Delsert\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Le groupe Bioclinic acquiert Biomega - ANDERA PARTNERS","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/","og_locale":"fr_FR","og_type":"article","og_title":"Le groupe Bioclinic acquiert Biomega - ANDERA PARTNERS","og_description":"&nbsp; Un peu plus d\u2019un an apr\u00e8s leur entr\u00e9e au capital du groupe Bioclinic, le consortium compos\u00e9 d\u2019IDIA Capital Investissement, de Socadif Capital Investissement et d\u2019Andera Partners accompagne la strat\u00e9gie de croissance externe de Bioclinic en acqu\u00e9rant 100\u00a0% du groupe Biomega. \u00a0 Le groupe cr\u00e9\u00e9 en 1995 par le Dr Philippe Dabi poursuit sa strat\u00e9gie...","og_url":"https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/","og_site_name":"ANDERA PARTNERS","article_published_time":"2020-05-04T12:04:16+00:00","article_modified_time":"2020-09-25T16:01:43+00:00","og_image":[{"width":1036,"height":503,"url":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2019\/01\/Bioclinic-2-1.png","type":"image\/png"}],"author":"Nicolas Delsert","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Nicolas Delsert","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/#article","isPartOf":{"@id":"https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/"},"author":{"name":"Nicolas Delsert","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/dce1d4a32f2d85f191a44527e202942c"},"headline":"Le groupe Bioclinic acquiert Biomega","datePublished":"2020-05-04T12:04:16+00:00","dateModified":"2020-09-25T16:01:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/"},"wordCount":569,"publisher":{"@id":"https:\/\/www.anderapartners.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/#primaryimage"},"thumbnailUrl":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2019\/01\/Bioclinic-2-1.png","articleSection":["andera Acto"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/","url":"https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/","name":"Le groupe Bioclinic acquiert Biomega - ANDERA PARTNERS","isPartOf":{"@id":"https:\/\/www.anderapartners.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/#primaryimage"},"image":{"@id":"https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/#primaryimage"},"thumbnailUrl":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2019\/01\/Bioclinic-2-1.png","datePublished":"2020-05-04T12:04:16+00:00","dateModified":"2020-09-25T16:01:43+00:00","breadcrumb":{"@id":"https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/#primaryimage","url":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2019\/01\/Bioclinic-2-1.png","contentUrl":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2019\/01\/Bioclinic-2-1.png","width":1036,"height":503},{"@type":"BreadcrumbList","@id":"https:\/\/www.anderapartners.com\/fr\/le-groupe-bioclinic-acquiert-biomega\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.anderapartners.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Le groupe Bioclinic acquiert Biomega"}]},{"@type":"WebSite","@id":"https:\/\/www.anderapartners.com\/fr\/#website","url":"https:\/\/www.anderapartners.com\/fr\/","name":"ANDERA PARTNERS","description":"","publisher":{"@id":"https:\/\/www.anderapartners.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.anderapartners.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.anderapartners.com\/fr\/#organization","name":"Andera Partners","url":"https:\/\/www.anderapartners.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg","contentUrl":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg","width":107,"height":44,"caption":"Andera Partners"},"image":{"@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/dce1d4a32f2d85f191a44527e202942c","name":"Nicolas Delsert","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/fca7b29302058c85588bc6bc3db9bd1e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fca7b29302058c85588bc6bc3db9bd1e?s=96&d=mm&r=g","caption":"Nicolas Delsert"}}]}},"_links":{"self":[{"href":"https:\/\/www.anderapartners.com\/fr\/wp-json\/wp\/v2\/posts\/4572","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.anderapartners.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.anderapartners.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.anderapartners.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.anderapartners.com\/fr\/wp-json\/wp\/v2\/comments?post=4572"}],"version-history":[{"count":0,"href":"https:\/\/www.anderapartners.com\/fr\/wp-json\/wp\/v2\/posts\/4572\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.anderapartners.com\/fr\/wp-json\/wp\/v2\/media\/2847"}],"wp:attachment":[{"href":"https:\/\/www.anderapartners.com\/fr\/wp-json\/wp\/v2\/media?parent=4572"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.anderapartners.com\/fr\/wp-json\/wp\/v2\/categories?post=4572"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}